Fig. 1From: UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective studyPatient selection process. CCRT: concurrent chemoradiotherapy; RT: radiotherapy; RH: radical hysterectomy; SCC: squamous cell carcinoma; CPT-11: irinotecan; NDP: nedaplatin; NAC: neoadjuvant chemotherapy; UGT1A1: uridine diphosphate glucuronosyltransferase 1A1Back to article page